- IN₹1.03tn
- IN₹1.06tn
- IN₹142.78bn
India's Marksans Pharma rises after Q1 profit boost
India's Mankind Pharma misses Q1 profit expectations on higher costs
Brief: Mankind Pharma Q1 Consol Net Profit At 5.36 Billion Rupees; Ibes Profit Est. 5.77 Billion Rupees
India's Mankind Pharma to buy Bharat Serums in a $1.6 billion deal (updated)
Mankind to acquire Bharat Serums for $1.6 billion, including debt
Brief: Mankind Pharma Says Board Considered And Approved Acquisition Of 100% Stake In Bharat Serums And Vaccines
Brief: Mankind Pharma Is Frontrunner In Bharat Serums Bid At Around $1.5 Billion - Bloomberg News
India's Mankind Pharma rises on block deals
Bain-backed Emcure Pharma's $234 mln India IPO draws $11 bln in bids
Media: India's Mankind Pharma in talks with PE firms for joint bid on Bharat Serums - The Hindu BusinessLine
Media: Indian pharma companies show interest in buying JB Chemicals from KKR - ET
NSEI Block Deal MANKIND PHAR 43,567 shares at 2290.05 INR
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment
Brief: Mankind Pharma March-Quarter Consol Net Profit At 4.71 Billion Rupees
India's weight in key MSCI equity index hits another high, to boost inflows (updated)
India's Canara Bank, Thermax rise on MSCI index inclusion
India’s weight in key MSCI equity index hits another high, to boost inflows
India's Mankind Pharma up on report of Bharat Serums acquisition plan
Brief: Mankind Pharma To Consider Proposals For Raising Funds